Ryman Healthcare (ASX:RYM) Beta: N/A (As of Jun. 26, 2026)


ASX:RYM Ryman Healthcare Ltd ASX:RYM
51 GF Score
Price A$1.87
GF Value A$4.71
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Ryman Healthcare Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Ryman Healthcare's Beta is Not available.

Ryman Healthcare  (ASX:RYM) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Ryman Healthcare Beta Related Terms

Ryman Healthcare Beta Historical Data

* Premium members only.

The historical data trend for Ryman Healthcare's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ryman Healthcare Beta Chart

Ryman Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ryman Healthcare Semi-Annual Data
Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:RYM
51GF Score
Ryman Healthcare Ltd ASX:RYM
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ryman Healthcare Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Ryman Healthcare (ASX:RYM) Overvalued in 2026?

Based on GuruFocus' analysis, Ryman Healthcare stock appears to be undervalued. The current stock price of A$1.87 is trading 60.3% below its estimated GF Value™ of A$4.71. GuruFocus considers Ryman Healthcare to be Possible Value Trap.

Key valuation signals for ASX:RYM:

  • Beta: N/A
  • GF Value™: A$4.71 vs. price of A$1.87 (60.3% below fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the ASX:RYM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ryman Healthcare Business Description

Other Exchanges RYM:New ZealandRH7:Germany
Address 92 Russley Road, P.O. Box 771, Christchurch, CT, NZL, 8042
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
51GF Score

Get the complete analysis for ASX:RYM

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.87
Price
A$4.71
GF Value